We offer a complete integrated solution for the development and manufacturing of lateral flow assays and reader systems.
Developing the next generation of rapid diagnostic products to meet the market need for simple to use, rapid, cost effective, portable systems.
Rapid diagnostic device for the quantitative measurement of kappa (K) and lambda (λ) immunoglobulin free light chains (FLCs).
Universal screening to combat #healthcare-associated #infections https://t.co/dRq2E7cDp5
20 March 2019
© Abingdon Health 2019